NIH-funded research R01 grant

New methods to improve gene delivery for studying brain circuits

Official title: Novel Cre-Dependent AAVs with Minimal Off-Target Expression to Study Neural Circuits

Funded at University of Virginia · NIH-11128555 · Data updated 2026-11-12

This study is all about finding better ways to deliver genes that help us learn about how the brain works, using special tools that make sure these genes only activate in the right places, and it's being tested in mice to make sure it works well.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startJuly 1, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$426,939
NIH project number5R01MH135905-02
Project IDNIH-11128555 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals with neurological conditions that could be studied using advanced gene delivery techniques.

Less likely to help

Patients with conditions unrelated to neural circuit function or those not amenable to gene therapy approaches may not benefit from this research.

What this research studies

This research focuses on enhancing the delivery of genes that help study neural circuits in the brain. It aims to improve the precision of gene expression by using a modified viral vector system that minimizes unintended gene activation. By addressing issues of off-target expression, the researchers hope to create more reliable tools for understanding brain function. This work involves testing new designs in laboratory mice to ensure that gene expression occurs only where intended.

Why it matters

Potential benefit: If successful, this research could lead to more accurate studies of brain function and potentially improve treatments for neurological disorders.

How similar studies have gone: Previous research has shown promise in improving gene delivery systems, but this specific approach to minimizing off-target effects is novel.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Perez-Reyes, Edward — University of Virginia
  • Study coordinator: Perez-Reyes, Edward

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.